3Mahabadi M, Alavian SM, Norouzi M, et al. Mutational analysis of re- verse transcriptase and surface proteins of patients with partial virological response during mono and combination antiviral therapies ingenotype D chronic hepatitis B [J]. ELectron Physician. 2016;8 (6): 2466-2474. 被引量：1
4Gebreegziabher D, Asfeha GG, Gebreyesus HA. Seroprevalence of hep- atitis B virus surface antigen (HBsAg) among clients visiting 'Tefera Hailu' memorial hospital, Sekota, Northern Ethiopia[J]. BMC Infect Dis. 2016; 16( 1 ):383.PMID:27503445. 被引量：1
5Fakhrmousavi SA, Hadadi A, Hosseini SH, et al. Immunogenicity of Four Doses of Double-Strength Intramuscular Hepatitis B[J]. Iran J Pathol. 2016;11 (2):127-132.PMID:27499773. 被引量：1
6Galson JD, Tr ti ck J, Clutterbuck EA, et al. Erratum to: B-cell reper- toire dynamics after sequential hepatitis B vaccination and evidence for cross-reactive B-cell activation[J]. Genome Med. 2016;8(1):81.PMID: 27488676. 被引量：1
7Zirabamuzale JT, Opio CK, Bwanga F, et al. Hepatitis B vires geno- types A and D in Uganda[J]. J Virus Erad. 2016;2(1):19-21.PMID: 27482430. 被引量：1
